Provided by Tiger Fintech (Singapore) Pte. Ltd.

Verve Therapeutics

10.93
+0.02000.18%
Post-market: 10.940.0100+0.09%16:40 EDT
Volume:2.24M
Turnover:24.59M
Market Cap:976.28M
PE:-5.20
High:11.08
Open:10.96
Low:10.93
Close:10.91
Loading ...

Sector Update: Health Care Stocks Fall in Afternoon Trading

MT Newswires Live
·
18 Jun

BUZZ-U.S. STOCKS ON THE MOVE-Red Cat, Nvidia Corp, Redwire

Reuters
·
18 Jun

Verve Therapeutics Cut to Hold From Buy by Canaccord Genuity

Dow Jones
·
17 Jun

Verve Therapeutics Up Over 74%, on Track for Record Percent Increase -- Data Talk

Dow Jones
·
17 Jun

Stock Track | Verve Therapeutics Soars 74% on Eli Lilly's $1.3 Billion Acquisition Deal

Stock Track
·
17 Jun

Verve Therapeutics downgraded to Hold from Buy at Canaccord

TIPRANKS
·
17 Jun

Deals of the day-Mergers and acquisitions

Reuters
·
17 Jun

Eli Lilly Shares Down 1.8%

THOMSON REUTERS
·
17 Jun

Verve Therapeutics Shares up 75% at $11.02 on Eli Lilly's Upto $1.3 Billion Buyout Deal

THOMSON REUTERS
·
17 Jun

Verve Therapeutics (VERV) was downgraded to a Hold Rating at William Blair

TIPRANKS
·
17 Jun

US STOCKS-Wall Street set to open lower as Middle East conflict continues

Reuters
·
17 Jun

Lilly to Buy Gene-Editing Partner Verve for up to $1.3 Billion in Cardiac Care Push

Reuters
·
17 Jun

Pre-Bell|U.S. Futures Dip; Verve Surges 75%; Regencell Bioscience Jumps Another 30%; Solar Stocks Plunge

Tiger Newspress
·
17 Jun

BUZZ-U.S. STOCKS ON THE MOVE-Verve Therapeutics, Lyell Immunopharma, Energy companies

Reuters
·
17 Jun

BRIEF-Lilly To Acquire Verve Therapeutics To Advance One-Time Treatments For People With High Cardiovascular Risk

Reuters
·
17 Jun

Verve Therapeutics Shares Jump 78.9% at $11.2 Premarket on Eli Lilly's up to $1.3 Billion Bid

THOMSON REUTERS
·
17 Jun

Lilly Shares Down 1.2% Premarket

THOMSON REUTERS
·
17 Jun

Eli Lilly to acquire Verve Therapeutics for $10.50 per share in cash

TIPRANKS
·
17 Jun

This five-star fund manager says even smart investors have been missing the greatest theme of our time

Dow Jones
·
17 Jun

Lilly to Acquire Verve Therapeutics to Advance One-Time Treatments for People With High Cardiovascular Risk

THOMSON REUTERS
·
17 Jun